Angela H. Colbers
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications
Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV.
Journal: Antimicrobial agents and chemotherapy
Published: July 17, 2026
Expediting a UNIVERSAL first-line regimen of a dolutegravir-emtricitabine-tenofovir alafenamide fixed-dose ratio for children living with HIV older than 4 weeks: a 24-week, open-label, single-arm, phase 1-2, pharmacokinetic, safety, and antiviral activity trial.
Journal: The lancet. HIV
Published: March 23, 2026
Infant HIV transmission despite maternal viral suppression: a case of post-weaning seroconversion.
Journal: The Journal of antimicrobial chemotherapy
Published: March 04, 2026
Factors influencing counseling on infant feeding options: a qualitative study with women living with HIV and their healthcare professionals in a high-income setting.
Journal: AIDS care
Published: January 27, 2026
Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial.
Journal: EClinicalMedicine
Published: January 08, 2026
Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate.
Journal: Clinical pharmacokinetics
Published: January 05, 2026
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.
Journal: Antimicrobial agents and chemotherapy
Published: September 26, 2025
Brain Structure of South African Children Born to Mothers on Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: August 14, 2025
The Effects on the Growth of HIV-exposed Uninfected Infants of Initiating Dolutegravir-based Versus Efavirenz-based cART in Late Pregnancy (DolPHIN-2).
Journal: The Pediatric infectious disease journal
Published: July 17, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIV.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 16, 2025
Correction: Optimising Paediatric HIV Treatment: Recent Developments and Future Directions.
Journal: Paediatric drugs
Published: May 05, 2025
Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children with HIV in the CHAPAS-4 trial.
Journal: AIDS (London, England)
Published: April 18, 2025
Last Updated: 09/26/2026